Has NOVARTIS had other FDA enforcement actions?

Yes. Argus HQ has recorded 5 total FDA actions tied to NOVARTIS: 0 warning letters, 1 recall, 4 approval records, and 0 Form 483 inspection citations.

What kind of FDA record is this?

This is an Argus HQ record of a FDA Drug Approval, tagged info severity by Argus HQ. FDA published the underlying record on 2026-07-16; Argus observed and indexed it on 2026-07-23.

Where can I verify this record directly with FDA?

The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

.hq

fda_approval · nda · info

NOVARTIS — NDA approval: FABHALTA (unspecified)

Name: FDA Drug Approval Record — NOVARTIS
Creator: Argus HQ
Published: 2026-07-16
License: https://argushq.ai/methodology

Event date: 2026-07-16 00:00:00Z
Observed: 2026-07-23 04:31:26Z
Source ID: NDA218276-7
Payload hash: 6e56d4289470f1374ff30bbe…

Summary

NOVARTIS received a priority supplemental NDA approval for FABHALTA (unspecified) on 2026-07-16. Dosage form: CAPSULE. Application #: NDA218276.

Entities

NOVARTIS

View source record ↗

Frequently asked questions

Has NOVARTIS had other FDA enforcement actions?: Yes. Argus HQ has recorded 5 total FDA actions tied to NOVARTIS: 0 warning letters, 1 recall, 4 approval records, and 0 Form 483 inspection citations.
What kind of FDA record is this?: This is an Argus HQ record of a FDA Drug Approval, tagged info severity by Argus HQ. FDA published the underlying record on 2026-07-16; Argus observed and indexed it on 2026-07-23.
Where can I verify this record directly with FDA?: The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). NOVARTIS — NDA approval: FABHALTA (unspecified). Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-approval-novartis-nda218276-7

MLA

"NOVARTIS — NDA approval: FABHALTA (unspecified)." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/events/fda-approval-novartis-nda218276-7.

Chicago

Argus HQ Research. "NOVARTIS — NDA approval: FABHALTA (unspecified)." Digital Empire Holdings LLC. Accessed July 23, 2026. https://argushq.ai/events/fda-approval-novartis-nda218276-7.

BibTeX

@misc{argushq_argushq_ai_events_fda_approval_novartis_nda218276_7_2026,
  title = {NOVARTIS — NDA approval: FABHALTA (unspecified)},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-approval-novartis-nda218276-7},
  note = {Accessed: July 23, 2026}
}

Informational only. Not legal, financial, or medical advice.